Bone Biologics Corp

General ticker "BBLG" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.1M

Bone Biologics Corp does not follow the US Stock Market performance with the rate: -35.9%.

Estimated limits based on current volatility of 4.7%: low 0.97$, high 1.07$

Factors to consider:

  • Current price 32.9% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.47$, 6.24$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.21$, 4.48$]

Financial Metrics affecting the BBLG estimates:

  • Negative: Non-GAAP EPS, $ of -49.66 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -91.49 <= 2.35
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31
  • Negative: -1.03 < Inventory ratio change, % of 0
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term BBLG quotes

Long-term BBLG plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $1.10MM $3.67MM $9.43MM
Operating Income $-1.10MM $-3.67MM $-9.43MM
Non-Operating Income $-0.51MM $2.18MM $0.48MM
Interest Expense $0.81MM $0.00MM $0.00MM
R&D Expense $0.08MM $1.58MM $6.91MM
Income(Loss) $-1.61MM $-1.48MM $-8.95MM
Profit(Loss) $-1.61MM $-1.48MM $-8.95MM
Stockholders Equity $6.58MM $5.95MM $2.91MM
Assets $6.68MM $8.50MM $3.74MM
Operating Cash Flow $-1.23MM $-3.57MM $-9.56MM
Financing Cash Flow $7.90MM $4.43MM $5.04MM
Earnings Per Share* $-37.35 $-31.15 $-34.01

* EPS are Split Adjusted, recent splits may be reflected with a delay.